Tanaka et al. “Activity of the multi-targeted kinase inhibitor, AT9283, in imatinib-resistant BCR-ABL positive leukemic cells.” Blood 116, no. 12 2010: 2089-2095. DOI: 10.1182/blood-2009-03-211466.

/in ,

Tanaka et al. “Activity of the multi-targeted kinase inhibitor, AT9283, in imatinib-resistant BCR-ABL positive leukemic cells.” Blood 116, no. 12 2010: 2089-2095. DOI: 10.1182/blood-2009-03-211466.